Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
FTY720 preserved islet β-cell mass by inhibiting apoptosis and increasing survival of β-cells in db/db mice.
Pattern of Uveitis in an Egyptian Population with Multiple Sclerosis: A Hospital-Based Study.
Immunomodulatory therapies delay disease progression in multiple sclerosis.
Multiple Sclerosis and Amyotrophic Lateral Sclerosis: Finding and then Losing an Association.
[Association between polymorphisms of cytokine genes and the rate of multiple sclerosis progression.]
[Therapeutic effect of encapsulated into the nanocontainers MBP immunodominant peptides on EAE development in DA rats].
Multiple rodent models and behavioral measures reveal unexpected responses to FTY720 and DMF in experimental autoimmune encephalomyelitis.
Historical overview of the rationale for the pharmacological use of prolonged-release fampridine in multiple sclerosis.
Expansion of Functional Human Mucosal-Associated Invariant T Cells via Reprogramming to Pluripotency and Redifferentiation.
Urinary catheterization may not adversely impact quality of life in multiple sclerosis patients.
Spreading of T-cell autoimmunity to cryptic determinants of an autoantigen.
Insights into TREM2 biology by network analysis of human brain gene expression data.
Merck Serono and Opexa Therapeutics Enter into Option and License Agreement for Development of Tcelna™ (imilecleucel-T) for Treatment of Multiple Sclerosis
Reduced sick leave in multiple sclerosis after one year of natalizumab treatment. A prospective ad hoc analysis of the TYNERGY trial.
Neuron-oligodendrocyte myelination co-culture derived from embryonic rat spinal cord and cerebral cortex.
The Immunomodulatory and Neuroprotective Effects of Mesenchymal Stem Cells (MSCs) in Experimental Autoimmune Encephalomyelitis (EAE): A Model of Multiple Sclerosis (MS).
Allelic combinations of immune-response genes as possible composite markers of IFN-β efficacy in multiple sclerosis patients.
Roles of the ubiquitin peptidase USP18 in multiple sclerosis and the response to interferon-β treatment.
Ampyra for Optic Neuritis in MS
Risk of cancer from azathioprine therapy in multiple sclerosis: a case-control study.
Cinnamon Ameliorates Experimental Allergic Encephalomyelitis in Mice via Regulatory T Cells: Implications for Multiple Sclerosis Therapy.
Treatment of a relapse-remitting model of multiple sclerosis with opioid growth factor.
Mass lesions in the brain: tumor or multiple sclerosis? Clinical and imaging characteristics and course from a single reference center.
Deep gray matter demyelination detected by magnetization transfer ratio in the cuprizone model.
Flash Pulmonary Edema in Multiple Sclerosis.
Pages
« first
‹ previous
…
259
260
261
262
263
264
265
266
267
…
next ›
last »